Statins for primary prevention: at what coronary risk is safety assured?

AIMS: Increasingly HMG CoA reductase inhibitors (statins) are being used for primary prevention of vascular disease in patients with a raised cholesterol but at low absolute risk of coronary heart disease (CHD). This study uses clinical trial results to explore the limits of absolute safety for stat...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jackson, Peter R, Wallis, Erica J, Haq, Ifti U, Ramsay, Lawrence E
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Science Inc 2001
Предметы:
Pharmacoepidemiology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014585/
https://ncbi.nlm.nih.gov/pubmed/11678788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.0306-5251.2001.01478.x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы